by Chris Masterjohn
The American Heart Journal has now published my letter criticizing a safety trial of the HDL-cholesterol-boosting drug anacetrapib for not measuring the drug's effect on vitamin E transport.
Index for Pubmed
Full Text of Letter — Effect of Cholesteryl Ester Transfer Protein Inhibitor on Vitamin E Transport Should Be Studied
Read more about the author, Chris Masterjohn, PhD, here.